Skip to main content
C

CytoRecovery

CytoRecovery develops microfluidic technology for the rapid separation and recovery of live cell populations from biological samples, ensuring cells remain in their native state for accurate downstream analysis. Their platform addresses the challenge of isolating viable cancer and other cell subpopulations, enhancing research capabilities in oncology, neurology, and regenerative medicine.

Blacksburg, United StatesFounded 201711300+ followers
Updated 20 months ago

Funding

$10.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

NS
Funding rounds are not available yet.

Founders

Product

Problem

Isolating viable cell populations from biological samples for downstream analysis is challenging, as traditional methods can damage cells or alter their native state, leading to inaccurate research results. Current cell separation techniques often lack the speed and precision required to effectively recover specific cell subpopulations.

Solution

CytoRecovery offers a microfluidic platform for the rapid and gentle separation, enrichment, and recovery of live cells from biological samples. The CytoR1 platform combines proprietary microfluidic chips, an electronics generator, fluidic controls, and integrated software to sort cells based on their intrinsic biophysical properties. This label-free approach ensures that cells remain in their native, untouched state, preserving viability and biological integrity for downstream applications. The platform is designed to integrate with standard inverted microscopes, providing researchers with a versatile tool for cell sorting in oncology, neurology, regenerative medicine, and other fields.

Target Audience

The primary target audience includes researchers and scientists in the fields of oncology, neurology, and regenerative medicine who require efficient and gentle cell separation techniques for downstream analysis and biomedical research.

Features

  • Proprietary microfluidic chips designed for gentle cell handling and high-resolution separation
  • Integrated electronics and fluidics system for precise control over the cell sorting process
  • CytoR1 software for intuitive experiment design, real-time monitoring, and data analysis
  • Label-free cell separation based on intrinsic biophysical properties, eliminating the need for antibodies or dyes
  • Compatibility with standard inverted microscopes for easy integration into existing laboratory workflows
  • CytoBuffer solution to maintain cell viability during electromanipulation experiments
  • Application notes demonstrating capabilities for recovering viable cell populations and enriching specific cell types
This profile is AI-generated and may contain inaccuracies.